#Diabetes Drug Increases Cancer Risk

Report in the Independent on the Diabetes drug Actos/Competact (active ingredient Piolitazone) with people showing an 88% increased risk of bladder cancer! That’s pretty high.


People prescribed Actos (piolitazone) for type-2 diabetes were found to increase the risk of bladder cancer by 83%.  Montreal researchers studied NHS records of 115,727 people.  Those prescribed it for over 2 years were at an 88% increased risk.

Dr David Juurlink, head of Clinical Pharmacology at Toronto Uni, said he thinks this is the single best study, which leaves little doubt that piolitazone is a potential risk factor for bladder cancer.

Research at McGill University & Montreal’s Jewish General Hospital.  Published in ‘British Medical Journal’ on 31.5.12.

Piolitazone can be given with the drug Metformin for controlling blood sugar. See my recent post on Metformin here too.

Leave a Reply

%d bloggers like this: